DCF — CCF MERCY MEDICAL CENTER
Enterprise Value: $-785.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-785.0M
Enterprise Value
$-244.1M
PV of Cash Flows
$-540.9M
PV of Terminal Value
$-871.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $365.5M | $-51.2M | -14.0% | $-66.7M | $-60.6M |
| Year 2 | $376.5M | $-49.0M | -13.0% | $-64.9M | $-53.7M |
| Year 3 | $387.8M | $-46.6M | -12.0% | $-63.0M | $-47.3M |
| Year 4 | $399.4M | $-46.0M | -12.0% | $-62.9M | $-42.9M |
| Year 5 | $411.4M | $-46.3M | -11.0% | $-63.7M | $-39.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-785.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$354.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14511678092389863
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5